v3.25.2
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended 36 Months Ended
Apr. 26, 2025
Apr. 27, 2024
Apr. 29, 2023
Apr. 26, 2025
Cash flows from operating activities        
Net income $ 100,952 $ 124,636 $ 151,941  
Adjustments to reconcile net income to cash provided by operating activities        
(Gain)/loss on disposal and impairment of assets 1,998 1,101 6,365  
(Gain)/loss on sale of investments (235) (1,199) 148  
Provision for doubtful accounts 851 511 1,546  
Depreciation and amortization 46,667 48,552 40,193  
Amortization of right-of-use lease assets 76,964 76,133 76,511  
Lease impairment/(settlement) 0 (1,175) 1,347  
Equity-based compensation expense 17,400 14,426 12,458  
Goodwill impairment 20,581 0 0  
Change in deferred taxes 5,116 (3,268) 3,895  
Change in receivables (1,906) (16,811) 53,675  
Change in inventories 12,792 19,877 32,311  
Change in other assets 8,701 10,303 24,377  
Change in payables (2,066) (8,606) 4,586  
Change in lease liabilities (78,609) (76,766) (77,811)  
Change in other liabilities (21,935) (29,587) (126,375)  
Net cash provided by operating activities 187,271 158,127 205,167  
Cash flows from investing activities        
Proceeds from disposals of assets 412 4,972 136  
Capital expenditures (74,280) (53,551) (68,812)  
Purchases of investments (6,990) (18,351) (9,092)  
Proceeds from sales of investments 11,994 24,816 24,483  
Acquisitions (29,525) (39,440) (16,835)  
Net cash used for investing activities (98,389) (81,554) (70,120)  
Cash flows from financing activities        
Payments on finance lease liabilities (663) (489) (123)  
Holdback payments for acquisitions 0 (5,000) (5,000)  
Stock issued for stock and employee benefit plans, net of shares withheld for taxes 12,350 10,872 2,857  
Repurchases of common stock (77,930) (52,773) (5,004)  
Dividends paid to shareholders (34,955) (32,665) (29,869)  
Dividends paid to minority interest joint venture partners [1] (1,414) (1,172) 0  
Net cash used for financing activities (102,612) (81,227) (37,139)  
Effect of exchange rate changes on cash and equivalents 1,081 (926) (86)  
Change in cash, cash equivalents and restricted cash (12,649) (5,580) 97,822  
Cash, cash equivalents and restricted cash at beginning of period 341,098 346,678 248,856 $ 248,856
Cash, cash equivalents and restricted cash at end of period 328,449 341,098 346,678 $ 328,449
Supplemental disclosure of non-cash investing activities        
Capital expenditures included in accounts payable $ 7,234 $ 5,952 $ 8,208  
[1] Includes dividends paid to joint venture minority partners resulting from the repatriation of dividends from our foreign earnings that we no longer consider permanently reinvested.